BOOK A DEMO

Sonic Incytes to Present at the Venture Summit Virtual Connect

Sonic Incytes Medical Corp., the developer of VelacurTM, has been selected to present its innovative technology at the upcoming Venture Summit Virtual Connect conference, hosted by youngStartup Ventures from July 6-8, 2021.

Sonic Incytes is among the top innovators from the technology, cleantech, life sciences, healthcare and fintech sectors chosen to present to an exclusive audience of venture capitalists, private investors, investment bankers, corporate investors and strategic partners.

Sonic Incytes CEO George Aliphtiras will present VelacurTM, the first handheld 3D liver health assessment solution to tackle the emerging fatty liver disease (NASH) crisis, on July 7.

For more information, visit: https://youngstartup.com/vcglobal21/

Sync up

with Sonic

Be in-the-know on all our latest news!

Subscribe to our e-newsletter.

Julia PinterMarketing Director

Julia Pinter brings over a decade of medical technology marketing experience spanning product commercialization, launch strategy, and sales enablement. Prior to joining Sonic Incytes, she served as Director of Global GI Product Marketing at PENTAX Medical, where she led global downstream marketing for the company’s largest portfolio — driving commercial launches of next-generation endoscopes, imaging systems, and AI platforms across the Americas, Europe, and Asia-Pacific. At Sonic Incytes, Julia leads downstream marketing initiatives to expand awareness and accelerate adoption of Velacur One®, translating its clinical and economic value into programs that support broader adoption of non-invasive liver assessment.